Kinesore

363571-83-9

C20H16Br2N4O4

DMSO : 125 mg/mL (233.14 mM; Need ultrasonic)

Others

Kinesore is an inhibitor of the KLC2-SKIP Interaction. IC50 & Target: KLC2-SKIP^[1]. In Vitro: Remarkably, in kinesore-treated cells, the microtubule network is entirely reorganized into a series of loops and bundles. In addition, the lysosomal compartment accumulates in a juxtanuclear position, where there are relatively few microtubules. At 50 uM kinesore, this phenotype is highly penetrant, with 95+/-2.4% (n=3, total of 200 cells) of cells exhibiting a reorganized nonradial microtubule network. In titration experiments, in cells treated for 1 h, this phenotype becomes apparent at a concentration of 25 uM kinesore, with relatively little effect at or below concentrations of 12.5 uM. The effect is reversible because a 2-h washout of kinesore from cells treated for 1 h led to the reestablishment of the radial microtubule array. This kinesore-induced reorganization of the microtubule network is observed in a panel of mammalian normal and cancer cell lines. In wild-type cells, 50 uM kinesore induces the remodeling of the microtubule network and the formation of extensive microtubule-rich projections. This phenotype is strongly suppressed in Kif5B knockout cells, confirming that microtubule remodeling induced by kinesore is dependent upon the presence of kinesin-1^[1].